The new report by Expert Market Research titled, ‘Global Cancer Immunotherapy Market Price, Report and Forecast 2022-2027, gives an in-depth analysis of cancer Immunotherapy, assessing the market based on its segments like therapy type, application, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/cancer-immunotherapy-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Historical Market Size (2020): USD 86.6 Billion
- Forecast CAGR (2022-2027): 9.7%
The high prevalence rate of cancer is the key factor for the increasing demand for cancer immunotherapy all across the globe. As per the World Health Organization, cancer is the second leading factor for mortality globally with around 9.6 million mortalities in 2018. Moreover, there were around 19.3 million cancer cases reported in 2020 which is further expected to increase to 30.2 million by 2040.
Among these, the most commonly found cancer is breast cancer among women and prostate cancer among men. In 2020, around 2.3 million women were diagnosed with breast cancer. Due to the high prevalence of cancer, governments and other organizations are increasing their awareness related to cancer and its potential prevention, which will drive the demand for cancer treatment all over the world.
Cancer is a fatal disease and can originate in any organ or tissue of the body where abnormal cells grow unnaturally and go beyond their usual boundaries to invade nearby body parts, also known as metastasizing. Immunotherapy is an effective treatment for cancer that aids and supports a patient’s immune system against cancer by providing a boost to the immune system’s natural defences to locate and attack cancer cells in the body.
By therapy type, the market is segmented into:
- Monoclonal Antibodies
- Cancer Vaccines
- Immune Check Point Inhibitors
By application, the market can be segmented into:
- Prostate Cancer
- Breast Cancer
- Skin Cancer
- Lung Cancer
The regional markets for the Global Cancer Immunotherapy Market can be separated into:
- North America
- United States of America
- United Kingdom
- Asia Pacific
- Latin America
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
North America and mostly the U.S. will hold the largest market share globally. It is due to the high prevalence of cancer in the region and high per capita healthcare expenditure. Due to this, high adoption of cancer immunotherapy is witnessed in the region. Moreover, with the increasing awareness related to cancer in emerging economies such as India, China, and ASEAN countries as well as growing medical tourism is expected to provide significant growth to the market in the emerging economies of Asia Pacific.
Key Market Players
The major players in the market include Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, and others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
About Us :
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA